Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ALTAREX CORP. (TSE: AXO)

No earlier versions found for this Subject.

Return to ALTAREX CORP. (TSE: AXO)

For all those who follow CYTO, CNTO, MEDX, CLTR, IDPH, PDLI and IMMU Altarex will be of great interest to you.

Altarex is one of the leading biotechnology companies in developing products which provide an integrated approach to the treatment and diagnosis of cancer. This approach is based on the company's platform technology, the Anti-idiotype induction therapy (AIT). AIT enhances the immune system's ability to produce a highly specific and effective antitumor response by generating both a humoral and cellular response.

I will keep this thread updated on a weekly basis. More information on Altarex will be posted here tonight.